Dr. Martin Schreiber Addresses TBI Trial Challenges at NeuroTrauma Symposium

PORTLAND, Ore. - Oct. 14, 2025 - PRLog -- Dr. Martin A. Schreiber, Adjunct Professor at the Uniformed Services University of the Health Sciences, delivered an in-depth presentation titled "Challenges in Traumatic Brain Injury Trials" at the 3rd Annual NeuroTrauma Symposium. The session explored the complexities of conducting high-quality clinical research in patients with traumatic brain injury (TBI) and the need for greater collaboration and innovation in trial design.

During his presentation, Dr. Schreiber discussed the scientific and logistical hurdles that make TBI research particularly difficult. He explained that variations in injury type, patient physiology, and treatment timing complicate the process of comparing outcomes across large populations. Determining how many patients to include in a study and which outcome measures best reflect recovery are ongoing challenges faced by investigators worldwide.

Dr. Schreiber shared findings from his published clinical trial on Tranexamic Acid, or TXA, which focused on patients with confirmed bleeding in the brain. His team found that giving TXA early in treatment helped improve both survival rates and brain function six months after injury. He explained that while this study showed real progress, running high-quality TBI trials remains a major challenge. They take strong coordination between hospitals, careful ethical review, and reliable data tracking to get meaningful results.

"The research community continues to face major obstacles in standardizing TBI trials," Dr. Schreiber noted. "The key to progress will be large-scale collaboration and consistent data that accurately capture patient recovery."

With his background as a Colonel in the U.S. Army Reserve and former Director of the Joint Theater Trauma System, Dr. Schreiber has seen how organized data collection and teamwork save lives on the battlefield.

He said those same methods could make civilian research stronger too. "When we bring military and civilian systems together, we can collect better data and run better trials," Dr. Schreiber explained. "Working side by side across trauma centers, the military, and universities is how we'll get better results for people with brain injuries."

The 3rd Annual NeuroTrauma Symposium featured experts from neurosurgery, critical care, and rehabilitation medicine and was led by the committed team from University of Chicago. ,it focused on emerging research and clinical innovation in neurotrauma care. Dr. Schreiber's session drew significant interest from attendees, generating discussion on the future of clinical trial methodology and patient-centered recovery metrics.

About Dr. Martin A. Schreiber

Dr. Martin A. Schreiber, M.D., is a trauma and critical care surgeon internationally recognized for his leadership in military and civilian medicine. He has authored more than 600 scientific publications and served in key leadership positions, including National Director of the Definitive Surgical Trauma Care Course. His research has been supported by the U.S. Department of Defense, the National Institutes of Health, and multiple industry partners.

https://www.martinschreiber.co/